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Abstract
Background: Ankle-brachial index (ABI) and indices of obesity are both use to indicate cardiovascular risk. However,
association between body composition indices and ABI, a measure of peripheral arterial disease, is inconsistent in
various study reports. In this study, we investigated the relationship between ABI and general and central indices of
obesity in Ghanaians without history of cardiovascular diseases.
Method: In a case–control design, ABI was measured in a total of 623 subjects and categorised into PAD (ABI ≤ 0.9,
n = 261) and non-PAD (ABI > 0.9, n = 362) groups. Anthropometric indices, BMI, waist circumference (WC), waist-hip
ratio (WHR) and waist-height ratio (WHtR) were also measured.
Results: PAD subjects had higher mean BMI (29.8 ± 8.7 vs. 26.5 ± 7.6 kg/m2, p = 0.043) and waist circumference
(95 ± 15 vs. 92 ± 24 cm, p = 0.034) than non-PAD subjects. In multivariable logistic regression models, having
BMI ≥ 30 kg/m2 increased the odds of both unilateral [OR (95 % CI): 2 (1.14–3.51), p < 0.01] and overall PAD
[2 (1.22–3.27), p < 0.01].
Conclusion: In indigenous Ghanaians in our study, PAD participants had higher BMI and waist circumference
than non-PAD participants. Also, halving BMI ≥ 30 kg/m2 was associated with twofold increase in the odds of
PAD.
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Background
Peripheral arterial disease (PAD) is one of the debilitat-
ing cardiovascular diseases (CVDs) among diabetes pa-
tients and the older general population [1]. Most PAD
cases remain undetected until later stages of the disease
when clinical symptoms become apparent [2]. Ankle-
brachial index (ABI), the ratio of systolic blood pressures
of the arteries of the ankle to the arteries of the upper
arm, is a simple, objective and non-invasive method of
screening for PAD [3]. The major risk factors for PAD
are diabetes and smoking [2], however, the prevalence of
smoking in Ghana is relatively low [4]. The prevalence
of symptomatic and asymptomatic PAD in diabetes pa-
tients far outweighs that of non-diabetic individuals [5].
Obesity, characterized by excess body fat, is recognized
as important factor for development of CVDs [6] includ-
ing PAD [7]. Obesity is assessed as body mass index
(BMI) for generalized adiposity, and waist circumference
(WC), waist-hip ratio (WHR) and waist-height ratio
(WHtR) for central adiposity [8]. Body composition and
adiposity exhibit ethnic diversity, with indigenous
Africans having different morphology compared to
Caucasians [9]. Also, there is no agreement on the best
index of adiposity associated with CVDs. For instance,
as some studies reported that, compared to BMI, indices
of central obesity such as WC, WHR and WHtR are bet-
ter determinant of CVD morbidity and mortality [10,
11]; other investigators found no superiority of these
measures of abdominal obesity to BMI in CVD risk pre-
diction [12]. In this study, we investigated the associ-
ation between various indices of obesity and PAD in
subjects without any history of CVD. We hypothesize
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that obesity increases the odds of PAD in our study
population.
Methods
This study was case control design, conducted within
the period of August, 2009 to June, 2010, at the Korle-
Bu Teaching Hospital in Accra, which is a 1500-bed ter-
tiary hospital and serves as the main referral hospital in
Ghana. ABI was measured in all the study population,
which were selected from two sources: (1) diabetes pa-
tients, selected systematically as every 3rd consecutive
patient visiting the diabetes clinic and consented to take
part in the study, and (2) non-diabetic individuals, in-
vited from the surrounding communities and conveni-
ently recruited into the study. All the study participants
were categorised as PAD and non-PAD based on the
ABI values. Individuals with stiff incompressible arteries
(ABI > 1.3), symptoms of classical intermittent claudica-
tion, history/medication of CVDs and those unable to
comprehend and comply with the protocol requirements
(psychological and/or cognitive disorders, failure to co-
operate, failure to sign the informed consent document)
were excluded from the study. The sample size was
estimated to detect correlation coefficient of 0.2 and 0.3
between BMI and ABI in PAD and non-PAD subjects
respectively; minimum of 186 subjects were required
to power the study at 80 % with type I error rate of
5 %. In all, 261 PAD patients and 362 non-PAD sub-
jects satisfied the inclusion criteria and were re-
cruited into the study. The study was approved by
the University of Ghana Medical School Ethical and
Protocol Review Committee (Protocol ID number:
MS-Et/M.2 – P.2.10/2009-2010) and all participants
gave written informed consent after the procedures
involved in the study were thoroughly explained to
them, following the general recommendations of the
Declaration of Helsinki.
Weight, height, waist and hip circumferences were
measured using standard protocol [8]. Briefly, body
weight was determined on twice using a homologated
electronic scale (Seca 770) following due calibration
(precision ± 0.1 kg), with the patient wearing light
clothing with shoes removed. Height was also measured
with a portable system (Seca 222) with the patient
shoeless in the upright position. Body mass index (BMI)
was calculated as weight (kg) divided by height squared
(m2). BMI < 18.5 Kg/m2 were considered underweight,
those within the range of 25–29.9 Kg/m2 were consid-
ered overweight and BMI ≥ 30 Kg/m2 were considered
obese. Waist circumference was measured with non-
elastic tape measure at the upper border of the iliac
crest, parallel to the floor without compressing the
skin. The reading was taken at the end of a normal
breath, and WHR < 0.9 & WC < 102 cm for males and
WHR <0.85 & WC < 88 cm for females were consid-
ered normal. WHtR was calculated as height divided
by WC, with WHtR <0.5 considered normal [8].
Blood pressure was measured three times, with a vali-
dated Blood Pressure Monitor (Omron 991X, Omron
Health Care, Japan), at the right upper arm of partici-
pants with an appropriate cuff size, after at least 5 min
rest, seated comfortably with arm and back support.
Hypertension was defined as subjects with BP ≥ 140/
90 mmHg and/or on antihypertensive medication.
Ankle and brachial blood pressures were measured in
all participants after a minimum of 5 min rest in a su-
pine position on an examination table in a temperature
controlled room. Blood pressure cuffs were applied to
bare ankles with the midpoint of the bladder over the
ankle arteries (dorsalis pedis and posterior tibial arteries)
approximately 2 cm above the medial malleolus. Systolic
blood pressure in both arms and ankles were obtained
using an 8-MHz handheld Doppler (LifeDop® 250, Sum-
mit Doppler). For each limb, the cuff was inflated rapidly
to the maximal inflation level and deflated at a rate of
2 mmHg per second until the systolic blood pressure be-
came audible. Measurements were obtained in the fol-
lowing order: right arm, right ankle, left ankle, and left
arm. ABI was calculated for each leg as the ratio of the
higher of the systolic blood pressure in the ankle (dorsa-
lis pedis and posterior tibia arteries) divided by the
higher of systolic blood pressure in the arm. ABI >0.9
was considered normal and PAD was defined as ABI ≤
0.9 in at least one leg [3]. Since none of the participants
had history/medication of CVDs, the level of athero-
sclerotic burden in PAD participants was estimated as
unilateral (ABI ≤ 0.9 in one leg) or bilateral (ABI ≤ 0.9 in
both legs) [13, 14]. Bilateral PAD has been reported to
indicate more diffuse vaso-occlusion, as well as reduced
arterial compliance, compared to unilateral PAD [13].
The data was analysed using IBM SPSS Version 20.
Socio-demographic and clinical characteristics of study
participants were analysed with student’s t-test for con-
tinuous variables and χ2 test for categorical variables.
Association between anthropometric indices and leg-
specific ABI were assessed using multivariable regression
with covariates forced into the model. The relationship
between obesity and PAD status was analysed using
logistic regression model with adjustment of covariates.
p < 0.05 was considered statistically significant.
Results
Of the 261 participants screened to have low ABI (≤0.9),
79 (12.6 %) participants had in the right leg alone, 96
(15.4 %) in the left leg only and 86 (13.8 %) in both legs.
Compared to participants without PAD, PAD partici-
pants had higher BMI, waist circumference, systolic BP
and heart rate, and also, most of them were on insulin
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(Table 1). Comparison of clinical characteristics between
diabetes patients and non-diabetic participants in the
study population is shown in Additional file 1: Table S1.
Across the various BMI groups, mean ABIs were signifi-
cantly lower in obese (BMI ≥30 kg/m2) participants in
both right and left legs (Fig. 1). Similarly, with respect to
the measures of central adiposity, participants with high
levels of waist circumference, WHR and WHtR had
lower mean ABIs in both right (Fig. 2) and left (Fig. 3)
leg values. Comparison of adjusted mean values of vari-
ous anthropometric characteristics between patients
with unilateral, bilateral and overall PAD is shown in
Additional file 1: Table S2.
In multiple regression analysis using the lower of ei-
ther right or left leg ABI as dependent variable, BMI,
waist circumference and waist-height ratio were associ-
ated with ABI in both crude and adjusted models in dia-
betes and non-diabetic participants, as well as overall
participants (Table 2). In multivariable logistic regression
analysis, male gender was associated with reduction in,
whereas hypertension increased, the odds of overall and
leg-specific PADs. Insulin usage increased the odds of
overall PAD, and cigarette usage also, increased the odds
of bilateral PAD. Generalized obesity (BMI ≥ 30 kg/m2)
was associated with increased odds of unilateral and
overall PADs and high waist circumference increased the
odds of bilateral PAD (Table 3).
Discussion
The main objective of this study was to investigate the
association between indices of obesity and ABI-
diagnosed PAD. Due to high burden of PAD in diabetes
patients [15], we included substantial number of diabetes
patients in order to obtain significant cases of PAD to
compare with non-PAD controls. The findings of this
study showed that, compared to non-PAD subjects,
mean BMI and Waist circumference were higher in
PAD subjects. Halving a higher BMI (≥30 kg/m2)
doubled the likelihood of PAD after adjustment of
some risk factors.
Table 1 Socio-demographic and clinical characteristics by PAD status
All participants (n = 623) PAD (n = 261) Non-PAD (n = 362) p
Age, yrs 54.1 ± 10.6 54.2 ± 10.7 53.5 ± 10.2 0.493
Female, n (%) 331 (51.3) 163 (26.2) 168 (27) 0.01
Diabetes, n (%) 358 (57.4) 192 (30.8) 166 (26.6) 0.245
Duration of diabetes, yrs 6.8 ± 5.9 7.4 ± 6.2 6.2 ± 5.2 0.068
Hypertension, n (%) 292 (46.9) 143 (23) 149 (23.9) <0.001
BMI, kg/m2 28 ± 8.2 29.8 ± 8.7 26.5 ± 7.6 0.043
Height, cm 163 ± 11 163 ± 12 164 ± 12 0.402
Waist circumference, cm 93 ± 13 95 ± 15 92 ± 24 0.034
Hip circumference, cm 102 ± 12 103 ± 14 101 ± 10 0.131
Waist-hip ratio 0.92 ± 0.09 0.92 ± 0.09 0.92 ± 0.23 0.873
Waist-height ratio 0.56 ± 0.07 0.59 ± 0.09 0.54 ± 0.07 0.855
Systolic BP, mmHg 133 ± 27 135 ± 25 130 ± 26 0.042
Diastolic BP, mmHg 80 ± 13 83 ± 13 79 ± 13 0.25
Pulse BP, mmHg 55 ± 19 56 ± 21 54 ± 15 0.318
Mean BP, mmHg 98 ± 15 98 ± 16 98 ± 15 0.296
Heart rate, bpm 70 ± 13 79 ± 16 63 ± 15 0.008
Employed, n (%) 0.127
Unemployed 232 (37.2) 108 (17.2) 124 (20)
Part-time employment 38 (6.1) 14 (2.2) 24 (3.9)
Full employment 353 (56.7) 136 (21.8) 217 (34.9)
Smoking, n (%) 0.22
Current 32 (5.1) 11 (1.7) 21 (3.4)
Former 111 (17.9) 44 (7) 67 ((10.9)
Never 480 (77) 203 (32.5) 277 (44.5)
Alcohol intake, n (%) 189 (30.3) 118 (18.9) 71 (11.4) 0.237
Insulin use, n (%) 177 (28.4) 121 (19.4) 56 (9) 0.01
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The relationship between BMI, an index of generalized
adiposity, and PAD reported in various studies is incon-
sistent. Similar to our findings, other studies reported
association between PAD (low ABI) and BMI. In Cardio-
vascular Health Study, Ix et al. reported that significant
association between BMI and ABI exist only in non-
smokers with good health status [16]. Also, the Hearts
of Brazil studies reported significant association between
ABI-diagnosed PAD versus BMI, waist circumference
and waist-hip ratio [17]. However, in contrast to our
findings, BMI ≥ 30 kg/m2 was reported to be protective
against PAD in Spanish population [18]. Others studies
found no association between ABI and BMI [19, 20].
This lack of association between BMI and PAD may be
explained by the masking effect of the U-shaped rela-
tionship between ABI and cardiovascular risk factors; in-
dividuals with ABI < 0.9 and ABI > 1.3 have similar high
CVD risk. Therefore, in the design of this study, exclu-
sion of subjects with ABI > 1.3 may partially explain the
significant association between ABI and anthropometric
indices.
Variation exist in blacks and Caucasian populations
with respect to the burden of obesity and PAD. Com-
parative analysis of black participants in the Jackson
Heart Study and Caucasians in Framingham Heart Study
showed that African-Americans have higher burden of
obesity and CVD risk factors, yet, the influence of obes-
ity to CVD burden is lesser than that of Caucasians [21].
Generally, blacks have high level of adiposity independ-
ent of diabetes and hypertension, which may also be as-
sociated with higher odds of PAD [22]. Moreover, ethnic
comparison of ABI in African-Americans and non-
Hispanic whites reported in both the GENOA [23] and
MESA [24] studies showed that African-Americans had
lower mean ABI in both studies, but similar prevalence
of PAD after adjustment of confounders.
Fig. 3 Mean ABI of the left leg across various central adiposity
categorisation
Fig. 1 Mean ABI across various BMI groups
Fig. 2 Mean ABI of the right leg across various central adiposity
categorisation
Table 2 Multivariable linear regression analysis of
Anthropometric Indices and ABI
Unadjusted model Model 1 Model 2
β p β p β p
All participants
BMI −0.16 <0.001 −0.14 0.001 −0.15 0.003
WC −0.17 <0.001 −0.15 <0.001 −0.13 0.003
WHR −0.07 0.108 −0.07 0.148 −0.03 0.434
WHtR −0.18 <0.001 −0.17 <0.001 −0.15 0.002
Diabetes patients
BMI −0.15 <0.001 −0.14 <0.001 −0.2 0.01
WC −0.15 0.006 −0.11 0.042 −0.09 0.119
WHR 0.02 0.684 0.04 0.503 0.05 0.344
WHtR −0.15 0.005 −0.12 0.044 −0.132 0.075
Non-diabetic subjects
BMI −0.26 <0.001 −0.22 <0.001 −0.21 0.001
WC −0.22 <0.001 −0.19 0.002 −0.19 0.003
WHR −0.04 0.536 −0.06 0.315 −0.07 0.293
WHtR −0.26 <0.001 −0.21 0.002 −0.2 0.003
Model 1: Adjusted for age and gender
Model 2: Adjusted for age, gender, height, mean BP, employment status,
diabetes and hypertension status and insulin use
BMI body mass index, WC Waist circumference, WHR waist-hip ratio, WHtR
waist-height ratio
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Indices of abdominal adiposity, waist circumference
and WHR, have been reported to be associated with
PAD in both prospective [11, 25] and cross-sectional
studies [10, 26]. BMI, waist circumference, WHR and
WHtR are indices use to estimate amount and distribu-
tion of body fat, which is linked to the pathophysiology
of vascular dysfunction [27]. In obese subjects, adipose
tissue is known to release several metabolites, cytokines
and hormones that modulates liver-derived lipoproteins,
clotting factors and inflammatory factors, which affect
the atherogenic environment of the vessel wall, favour-
ing the development of atherosclerotic vascular diseases
such as PAD [28]. Adipose tissue–derived factors also
influence gene expression and function of cells involved
in vascular homeostasis, such as endothelial cells, ar-
terial smooth muscle cells, and monocytes/macro-
phages [6].
The findings of our study show that means of WHR
were similar between PAD and non-PAD subjects, and
in contrast to other studies [27]. Also, higher waist cir-
cumference and WHR, biomarkers of central obesity,
were not associated with PAD. Compared to Caucasians,
body composition of black ethnicity is associated differ-
ently with CVD risk profile. With similar BMI and waist
circumference, computed tomographic analysis showed
that African-Americans had lower visceral fat than His-
panics and Caucasians [9]. WHR and waist circumfer-
ence are indices of fat accumulation in the abdominal
viscera and intra-abdominal organs, with or without ref-
erence to fat accumulation in gluteo-femoral region re-
spectively. As a marker of visceral fat accumulation,
WHR and waist circumference reflect the relative inabil-
ity of subcutaneous adipose tissue to act as a protective
metabolic sink for the clearance and storage of extra en-
ergy derived from dietary triglycerides, leading to ectopic
fat deposition in visceral adipose depots [29]. Visceral
adipose tissue and its adipose-tissue resident macro-
phages produce more pro-inflamatory cytokines like
tumor necrosis factor-alpha and interleukin-6, and less
athero-protective adiponectin, making visceral fat meas-
urement a proxy for the level of atherogenicity [30].
However, subcutaneous and visceral fat distribution ex-
hibit ethnic variation, with Caucasians accumulating
more fat in the abdominal region which can be readily
Table 3 Multivariable logistic regression of obesity and PAD status
PAD (at least one leg) Unilateral PAD Bilateral PAD
β (95 % CI) β (95 % CI) β (95 % CI)
Age 0.99 (0.98–1.01) 0.99 (0.98–1.01) 1.01 (0.98–1.04)
Height 1.36 (0.25–7.51) 1.41 (0.25–7.84) 0.248 (0.03–2.32)
Mean BP 0.99 (0.98–1) 0.99 (0.98–1.01) 0.99 (0.97–1.01)
Male gender 0.58 (0.38–0.88) 0.62 (0.42–0.92) 0.49 (0.26–0.93)
Employment (Ref: Full–time)
Part-time 0.78 (0.38–1.62) 0.77 (0.37–1.59) 1.33 (0.75–4.87)
Unemployed 1.27 (0.86–1.86) 1.27 (0.86–1.86) 1.31 (0.5–3.43)
Diabetes 1.01 (0.65–1.55) 1.04 (0.68–1.59) 0.89 (0.46–1.72)
Insulin use 1.92 (1.03–3.72) 1.85 (0.96–3.57) 1.89 (0.46–1.72)
Hypertension 2.11 (1.29–3.45) 1.82 (1.03–3.19) 3.19 (1.56–6.52)
Alcohol intake 1.08 (0.74–1.58) 0.89 (0.57–1.39) 1.58 (0.91–2.73)
Cigarette usage 1.21 (0.76–1.95) 0.93 (0.93–3.86) 2.15 (1.09–4.25)
Anthropometrya
BMI groups (Ref: Normal)
Overweight 1.19 (0.78–1.82) 1.68 (0.72–1.88) 1.25 (0.64–2.42)
Obese 2 (1.22–3.27) 2 (1.14–3.51) 1.94 (0.94–3.99)
WC (Ref: Normal)
High 1.28 (0.84–1.95) 1.39 (0.78–2.24) 1.34 (0.61–2.1)
WHR (Ref: Normal)
High 1.08 (0.72–1.62) 1.12 (0.7–1.77) 0.99 (0.54–1.86)
WHtR (Ref: Normal)
High 1.07 (0.68–1.67) 1.02 (0.63–1.67) 1.38 (0.64–2.98)
aAdjusted for age, gender, height, mean BP, diabetes status, hypertension status, diabetes and hypertension medication, smoking and alcohol intake
WC waist circumference, WHR waist-hip ratio; WHtR waist-height ratio
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mobilised, as blacks, on the contrary, accumulate fat in
the subcutaneous region. In addition, visceral fat accu-
mulation correlates with waist circumference better in
Caucasians than Africans [9, 29]. This may partially ex-
plain the non-significant association between indices of
central adiposity and risk of PAD prevalence in our
study population.
The strength of this study is the relatively large sample
size of equivalent proportion of PAD and non-PAD sub-
jects, selected by systematic random sampling, and ABI
measured in temperature controlled room. Also, subjects
with stiff arteries, intermittent claudication and history
of CVDs were excluded from the study. The major limi-
tations include the study being a cross sectional clinic-
based design, and hence, we cannot infer causality. Also,
plasma biomarkers were not analysed to study the
pathophysiological mechanisms relating obesity to PAD.
Conclusion
The findings of this study show that, in Ghanaian with-
out any history of CVD, PAD patients had higher BMI
and waist circumference than non-PAD subjects. In
addition, halving a BMI ≥ 30 kg/m2 increased the odds
of PAD by twofold.
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